NeuroSense Therapeutics Ltd.
NRSN | NASDAQ
$1.99
-$0.14 (-6.57%)
At close: Oct 30, 2026, 4:00 PM ET
$1.99
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
TTM Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 | Q4 2020 Dec 31, 2020 | Q3 2020 Sep 30, 2020 | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -11.09M | -9.66M | -8.57M | -9.25M | -9.9M | -11.42M | -12.21M | -12.66M | -12.65M | -12.74M | -13.17M | -13.28M | -13.55M | -11.82M | -9.38M | -6.74M | -5.59M | -5.06M | -5.3M | -4.67M | -2.89M | -1.77M | -650K | -325K |
Interest Income | n/a | n/a | n/a | 2.17M | 2.17M | -1.55M | 2.15M | -27K | 40K | 3.97M | 608K | 752K | 1.26M | 1.05M | 716K | 583K | 11K | 11K | 11K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -11.13M | -9.72M | -8.66M | -7.16M | -10.21M | -11.36M | -8.43M | -12.8M | -10.32M | -10.52M | -14.29M | -12.55M | -12.34M | -9.29M | -7.19M | -4.63M | -4.04M | -5.04M | -5.26M | -4.64M | -2.83M | -1.73M | -622K | -311K |
Net Income | -11.13M | -9.72M | -8.66M | -7.16M | -10.21M | -11.36M | -8.43M | -12.8M | -10.32M | -10.52M | -14.29M | -12.55M | -12.34M | -9.29M | -7.19M | -4.63M | -4.04M | -5.04M | -5.26M | -4.64M | -2.83M | -1.73M | -622K | -311K |
Selling & General & Admin | 4.86M | 4.21M | 3.82M | 4.19M | 4.2M | 4.85M | 5.17M | 5.28M | 5.31M | 5.82M | 6.16M | 6.31M | 7.14M | 6.9M | 5.65M | 4.38M | 2.51M | 1.04M | 822K | 427K | 393K | 254.5K | 116K | 58K |
Research & Development | 6.23M | 5.45M | 4.75M | 5.07M | 5.7M | 6.57M | 7.03M | 7.37M | 7.34M | 6.93M | 7.01M | 6.97M | 6.42M | 4.92M | 3.73M | 2.36M | 3.08M | 4.02M | 4.48M | 4.25M | 2.5M | 1.51M | 534K | 267K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 11.09M | 9.66M | 8.57M | 9.25M | 9.9M | 11.42M | 12.21M | 12.66M | 12.65M | 12.74M | 13.17M | 13.28M | 13.55M | 11.82M | 9.38M | 6.74M | 5.59M | 5.05M | 5.27M | 4.63M | 2.83M | 1.73M | 622K | 311K |
Interest Expense | 17K | 47K | 88K | 79.5K | 2.48M | 793K | 764K | 1.04M | -1.06M | 598K | 596K | 355K | 68K | 1.22M | 1.22M | 1.19M | 1.18M | 21K | 13K | 13K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.09M | 9.66M | 8.57M | 9.25M | 9.9M | 11.42M | 12.21M | 12.66M | 12.65M | 12.74M | 13.17M | 13.28M | 13.55M | 11.82M | 9.38M | 6.74M | 5.59M | 5.06M | 5.3M | 4.67M | 2.89M | 1.77M | 650K | 325K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.28M | 1.28M | 1.27M | 1.27M | 1.08M | 990.45K | 902.75K | 770.25K | 768.95K | 681.15K | 681.15K | 589.25K | 589.1K | 579.65K | 579.75K | 565.65K | 547.2K | 538.4K | 547.2K | 279.1K | 279.15K | 279.15K | 272.7K | 272.7K |
Shares Outstanding (Diluted) | 1.28M | 1.28M | 1.27M | 1.27M | 1.08M | 990.45K | 902.75K | 770.25K | 768.95K | 681.15K | 681.15K | 589.25K | 589.1K | 579.65K | 579.75K | 565.65K | 547.2K | 538.4K | 547.2K | 279.15K | 279.2K | 279.2K | 272.7K | 272.7K |
EPS (Basic) | -8.91 | -7.97 | -7.57 | -6.67 | -11.81 | -13.95 | -10.60 | -17.25 | -15.25 | -16.45 | -22.20 | -20.60 | -20.40 | -15.58 | -12.63 | -8.33 | -7.33 | -11.15 | -13.50 | -12.94 | -10.28 | -6.28 | -2.28 | -1.14 |
EPS (Diluted) | -8.91 | -7.97 | -7.57 | -6.67 | -11.81 | -13.95 | -10.60 | -17.25 | -15.25 | -16.45 | -22.20 | -20.60 | -20.40 | -15.58 | -12.63 | -8.33 | -7.33 | -11.15 | -13.50 | -12.94 | -10.28 | -6.28 | -2.28 | -1.14 |
EBITDA | -11.07M | -9.64M | -8.55M | -7.06M | -7.71M | -11.08M | -6M | -10.65M | -10.27M | -8.33M | -14.3M | -12.22M | -12.3M | -10.75M | -8.65M | -6.17M | -5.58M | -5.06M | -4.15M | -3.2M | -1.07M | 44K | 28K | 14K |
EBIT | -11.09M | -9.66M | -8.57M | -7.08M | -7.73M | -11.11M | -6.01M | -10.68M | -10.3M | -8.36M | -14.33M | -12.25M | -12.33M | -10.77M | -8.67M | -6.17M | -5.59M | -5.06M | -5.29M | -4.67M | -2.89M | -1.77M | -650K | -325K |
Depreciation & Amortization | 16K | 17.5K | 18.75K | 20.25K | 21.5K | 21.25K | 16K | 34K | 31.75K | 26.5K | 27.25K | 24.25K | 22K | 22.75K | 22K | 2.25K | 2.25K | 2.25K | 1.12M | 1.45M | 1.77M | 1.77M | 650K | 325K |
Add to Watchlist
Select watchlists to add or remove NRSN